Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula

L Zhao, H Zhang, N Li, J Chen, H Xu, Y Wang… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Network pharmacology is a new discipline based on
systems biology theory, biological system network analysis, and multi-target drug molecule …

Short-chain fatty acids in chronic kidney disease: Focus on inflammation and oxidative stress regulation

G Magliocca, P Mone, BR Di Iorio, A Heidland… - International Journal of …, 2022 - mdpi.com
Chronic Kidney Disease (CKD) is a debilitating disease associated with several secondary
complications that increase comorbidity and mortality. In patients with CKD, there is a …

[HTML][HTML] The role of IL-10 in kidney disease

W Wei, Y Zhao, Y Zhang, H Jin, S Shou - International …, 2022 - Elsevier
Kidney disease is a global health problem with high mortality and socioeconomic burden,
including acute kidney injury (AKI), chronic kidney disease (CKD), diabetic nephropathy …

[HTML][HTML] AI-Powered Renal Diet Support: Performance of ChatGPT, Bard AI, and Bing Chat

A Qarajeh, S Tangpanithandee, C Thongprayoon… - Clinics and …, 2023 - mdpi.com
Patients with chronic kidney disease (CKD) necessitate specialized renal diets to prevent
complications such as hyperkalemia and hyperphosphatemia. A comprehensive …

Renal-Protective Roles of Lipoic Acid in Kidney Disease

SF Kamt, J Liu, LJ Yan - Nutrients, 2023 - mdpi.com
The kidney is a crucial organ that eliminates metabolic waste and reabsorbs nutritious
elements. It also participates in the regulation of blood pressure, maintenance of electrolyte …

The pathogenesis of end-stage renal disease from the standpoint of the theory of general pathological processes of inflammation

E Gusev, L Solomatina, Y Zhuravleva… - International journal of …, 2021 - mdpi.com
Chronic kidney disease can progress to end-stage chronic renal disease (ESRD), which
requires the use of replacement therapy (dialysis or kidney transplant) in life-threatening …

Mesenchymal stem cells attenuate renal fibrosis via exosomes-mediated delivery of microRNA Let-7i-5p antagomir

J Jin, F Qian, D Zheng, W He, J Gong… - International journal of …, 2021 - Taylor & Francis
Background Renal fibrosis is a chronic and progressive process affecting kidneys in chronic
kidney disease (CKD). Mesenchymal stem cells-derived exosomes (MSCs-Exo) have been …

Association between triglyceride-glucose index and chronic kidney disease: A cohort study and meta-analysis

X Ren, M Jiang, L Han, X Zheng - Nutrition, Metabolism and Cardiovascular …, 2023 - Elsevier
Background and aims Nowadays, the relationship between triglyceride-glucose (TyG) index
and chronic kidney disease (CKD) is still controversial. We aimed to prospectively …

Melatonin treatment in kidney diseases

M Markowska, S Niemczyk, K Romejko - Cells, 2023 - mdpi.com
Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the
work of the superior biological clock and consequently affects many processes in the human …

The m6A demethylase FTO promotes renal epithelial-mesenchymal transition by reducing the m6A modification of lncRNA GAS5

X Li, Y Li, Y Wang, X He - Cytokine, 2022 - Elsevier
Background Renal interstitial fibrosis (RIF) is the main pathological change of a variety of
chronic kidney diseases (CKD). Epigenetic modifications of fibrosis-prone genes regulate …